Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bone marrow derived mesenchymal stem cells (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
msc-ntf cells (2 trials)
nurown (2 trials)
Amyotrophic Lateral Sclerosis (Phase 3)
Motor Neuron Disease (Phase 3)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Sclerosis (Phase 2)
Trials (6 total)
Trial APIs (4 total)